IMPROVE-PD is a European Action titled: ‘Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis’.

IMPROVE PD connects leading researchers who will collaborate in the shared goal of understanding the mechanisms of inflammation-driven cardiovascular disease in Peritoneal Dialysis (PD) patients, developing individualized approaches to identify those at risk, and testing new therapies in them.

Network-wide and local training activities including academies and satellite modules associated with large nephrology conferences, combined with individual research projects, intersectoral secondments and short laboratory visits, will provide key generic skills including valorisation, entrepreneurship and intellectual property management and will prepare ESRs for future roles as highly skilled research leaders in Europe.

WHAT IS IMPROVE-PD

DOWNLOAD OUR NEWSLETTER

ACADEMY IN MADRID

ACADEMY IN CARDIFF

ACADEMY IN HEIDELBERG

FOLLOW US

IMPROVE-PD Follow

Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis. An EU funded consortium of 22 organisations (GA 812699)

Retweet on Twitter IMPROVE-PD Retweeted

KDIGO @gokdigo ·

6 Feb

KDIGO invites you to share your feedback on the Scope of Work for the KDIGO Controversies Conference on Kidney Disease and Heart Failure. You can download the SOW and share comments via the feedback survey on the conference website through February 21: https://kdigo.co/Kidney-Disease-Heart-Failure-Controversies-Conference…

Reply on Twitter 1754922663976292706 Retweet on Twitter 1754922663976292706 15 Like on Twitter 1754922663976292706 52 Twitter 1754922663976292706

Retweet on Twitter IMPROVE-PD Retweeted

Marie Skłodowska-Curie Actions @mscactions ·

8 Jan

Introducing our new financial guide, simplifying #MSCA project management!

✔️ Ideal for applicants, coordinators, managers
🚀 Covers Doctoral Networks, Fellowships, Staff Exchanges, COFUND programmes
📈 Clarifies recruitment, reporting, eligibility

Check it out below ⤵️

Reply on Twitter 1744282798507401578 Retweet on Twitter 1744282798507401578 75 Like on Twitter 1744282798507401578 166 Twitter 1744282798507401578

Retweet on Twitter IMPROVE-PD Retweeted

Marie Skłodowska-Curie Actions @mscactions ·

7 Nov 2023

Today marks the 156th anniversary of the extraordinary Marie Skłodowska-Curie! 🎂 Her legacy thrives through the #MSCA, empowering researchers worldwide.

Join the celebration and discover how you can contribute to the spirit of innovation she ignited. 👇

Reply on Twitter 1721802382776901982 Retweet on Twitter 1721802382776901982 141 Like on Twitter 1721802382776901982 430 Twitter 1721802382776901982

IMPROVE-PD @improvepd ·

25 Sep 2023

Lessons from animal models: unraveling kidney fibrosis.
Read more here!:
Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet #mdpiantioxidants via @antioxidants_OA

Reply on Twitter 1706301350521286820 Retweet on Twitter 1706301350521286820 1 Like on Twitter 1706301350521286820 Twitter 1706301350521286820

Load More

IMPROVE-PD is funded by the Horizon 2020 Framework Programme of the European Union through the Marie Skłodowska-Curie Programme as an Innovative Training Network (ITN-ETN).

The aim of this Programme is to train a new generation of creative, entrepreneurial and innovative early-stage researchers, able to face current and future challenges and to convert knowledge and ideas into products and services for economic and social benefit.

The IMPROVE PD consortium connects leading academic and industrial researchers in this field internationally, who will cooperate in the shared goal of understanding the mechanisms of inflammation-driven cardiovascular disease in PD patients, developing individualized approaches to identify those at risk, and testing new therapies in them.